Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy

被引:167
|
作者
Karagas, MR
McDonald, JA
Greenberg, ER
Stukel, TA
Weiss, JE
Baron, JA
Stevens, M
机构
[1] DARTMOUTH COLL SCH MED,NORRIS COTTON CANC CTR,HANOVER,NH 03755
[2] UNIV VERMONT,DEPT MATH & STAT,BURLINGTON,VT 05405
关键词
D O I
10.1093/jnci/88.24.1848
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Human evidence that ionizing radiation is carcinogenic first came from reports of nonmelanoma skin cancers (NMSCs) on the hands of workers using early radiation devices. An increased risk of NMSC has been observed among uranium miners, radiologists, and individuals treated with x rays in childhood for tinea capitis (ringworm of the scalp) or for thymic enlargement; NMSC is one of the cancers most strongly associated with the atomic bombing of Hiroshima and Nagasaki. Although exposure to ionizing radiation is a known cause of NMSC, it is not yet clear whether therapeutic radiation causes both major histologic types of NMSC, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Additionally, the potentially modifying effects, such as latency, age when treated, and type of treatment, are not well understood. Purpose: We investigated the relative risk of BCC and SCC associated with previous radiation therapy and evaluated these risks in relation to age and time since initial treatment and the medical condition for which radiation therapy was given. Methods: The study group comprised individuals diagnosed with at least one BCC or SCC from January 1980 through February 1986, who were recruited to participate in a skin cancer prevention trial designed to test whether oral beta-carotene supplementation would reduce the risk of new NMSCs. Patients were identified through the dermatology and pathology records of academic medical centers in Hanover, NH; Los Angeles, CA; San Francisco, CA; and Minneapolis, MN. Each participant completed a questionnaire detailing lifetime residence, pigmentary characteristics, occupational and recreational sun exposure, and history of radiation therapy. At enrollment, a study dermatologist assessed skin type (tendency to burn or tan) and extent of actinic skin damage. Participants were followed with an annual dermatologic examination for an average of 4 years. Of the 5232 potentially eligible individuals, 1805 were enrolled in the trial. We exclused 112 patients who reported previous radiation therapy for skin cancer only and three with missing information on whether they were ever treated with radiation therapy, leaving 1690 patients for the analysis. Approximately 4% of the patients died or discontinued participation for other reasons during each study year. We examined time to occurrence of first new histopathologically confirmed BCC and SCC during the follow-up period in relation to history of radiation therapy (for reasons other than NMSC) using a proportional hazards model. A multiple end points survival model was used to compare the rate ratios (RRs) for BCC and SCC. We also used a longitudinal method of analysis to compute the RR of total new BCC and SCC tumors per person per study year associated with radiation therapy. Using this method, we additionally assessed the potential modifying effects of age at treatment, latency, and type of therapy. All P values were derived from two-sided statistical tests of significance. Results: Among the participants we studied, 597 developed a new BCC (n = 1553 tumors) and 118 developed a new SCC (n = 179 tumors). The time to first new BCC, but not SCC, was associated with prior radiation therapy (RR = 1.7; 95% confidence therapy (RR = 1.7; 95% confidence interval [CI] = 1.4-2.0 and RR = 1.0; 95% CI = 0.6-1.7, respectively; P = .03 for the difference between the RRs). The RR of total BCC tumors was slightly higher (RR = 2.3; 95% CI = 1.7-3.1), but it was still unity for SCC (RR = 1.0; 95% CI = 0.5-1.9). BCC risk appeared to increase with younger age at exposure and time since initially treated, although these effects were only marginally statistically significant (P for trend = .06 and . 07, respectively). Also, risk of BCC was more strongly related to treatment for acne (RR = 3.3; 95% CI = 2.1-5.2) than other conditions. Conclusions and Implications: Our data suggest that exposure to therapeutic radiation is associated with BCC but not with SCC. Several aspects of the relationship of ionizing radiation exposure to the risk for skin cancer are not yet fully understood and warrant continued investigation.
引用
收藏
页码:1848 / 1853
页数:6
相关论文
共 50 条
  • [41] INTERFERON REDUCES RECURRENCES OF BASAL-CELL AND SQUAMOUS-CELL CANCERS
    IKIC, D
    PADOVAN, I
    PIPIC, N
    CAJKOVAC, V
    KUSIC, Z
    DAKOVIC, N
    GREGUREKNOVAK, T
    SOLDOBELIC, A
    SPAVENTI, S
    BELICZA, M
    FERENCIC, Z
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1995, 34 (01) : 58 - 60
  • [42] High incidence of second basal cell skin cancers
    Levi, Fabio
    Randimbison, Lalao
    Maspoli, Manuela
    Te, Van-Cong
    La Vecchia, Carlo
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (06) : 1505 - 1507
  • [43] RADIATION-THERAPY OF FREQUENT SKIN NEOPLASMS - RESULTS OF TREATMENT CONCERNING BASAL-CELL CARCINOMA, SQUAMOUS-CELL CARCINOMA AND MELANOMA
    SUHR, P
    ROTTINGER, EM
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1989, 131 (48): : 916 - 919
  • [44] Association of basal cell skin cancers with other cancers (United States)
    Gary D. Friedman
    Irene S. Tekawa
    Cancer Causes & Control, 2000, 11 : 891 - 897
  • [45] Association of basal cell skin cancers with other cancers (United States)
    Friedman, GD
    Tekawa, IS
    CANCER CAUSES & CONTROL, 2000, 11 (10) : 891 - 897
  • [46] Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin
    Kwan, W
    Wilson, D
    Moravan, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (02): : 406 - 411
  • [47] FIBRONECTIN IN BASAL-CELL AND SQUAMOUS-CELL CARCINOMAS OF SKIN
    HILL, AJ
    TALBOT, IC
    JOURNAL OF PATHOLOGY, 1982, 138 (01): : 77 - 78
  • [48] Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study
    Puig, Susana
    Sampogna, Francesca
    Tejera-Vaquerizo, Antonio
    JAMA DERMATOLOGY, 2016, 152 (10) : 1172 - 1173
  • [49] Differential Activation of Cell Death Pathways After Ionizing Radiation in Luminal and Basal Breast Cancer Cell Lines
    Horton, Janet K.
    Fels, Diane R.
    Kung, Hsiu-Ni
    Zhou, Yingchun
    Ashcraft, Kathleen
    Dewhirst, Mark W.
    Chi, Jen-Tsan Ashley
    JOURNAL OF WOMENS HEALTH, 2012, 21 (10) : 992 - 992
  • [50] Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck
    Allman, R
    Cowburn, P
    Mason, M
    BRITISH JOURNAL OF CANCER, 2000, 83 (05) : 655 - 661